Current Trends in Glioblastoma Multiforme Treatment: Radiation Therapy and Immune Checkpoint Inhibitors
Brain Tumor Research and Treatment · 2013
DOI: 10.14791/btrt.2013.1.1.2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain Tumor Research and Treatment, 2013. Verfasst von Sarah Nicholas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Doris Duke Charitable Foundation to Johns Hopkins University School of Medicine.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) is the most common primary brain cancer. Even with aggressive combination therapy, the median life expectancy for patients with GBM remains approximately 14 months. In order to improve the outcomes of patients with GBM, the development of newer treatments is critical. The concept of using the immune system as a therapeutic option has been suggested for several decades; by harnessing the body's adaptive immune mechanisms, immunotherapy could provide a durable and targeted treatment against cancer. However, many cancers, including GBM, have developed mechanisms that protect tumor cells from being recognized and eliminated by the immune system. For new immunotherapeutic regimens to be successful, overcoming immunosuppression via immune checkpoint signaling should be taken into consideration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- Department of Neurosurgery, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, CA, USA.
- Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. ; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Förderung
- Doris Duke Charitable Foundation to Johns Hopkins University School of Medicine
Zitieren
APA
Nicholas, S., Mathios, D., Ruzevick, J., Jackson, C., Yang, I., & Lim, M. (2013). Current Trends in Glioblastoma Multiforme Treatment: Radiation Therapy and Immune Checkpoint Inhibitors. Brain Tumor Research and Treatment. https://doi.org/10.14791/btrt.2013.1.1.2
Vancouver
Nicholas S, Mathios D, Ruzevick J, Jackson C, Yang I, Lim M. Current Trends in Glioblastoma Multiforme Treatment: Radiation Therapy and Immune Checkpoint Inhibitors. Brain Tumor Research and Treatment. 2013. doi:10.14791/btrt.2013.1.1.2
BibTeX
@article{Nicholas2013,
author = {Nicholas, Sarah and Mathios, Dimitris and Ruzevick, Jacob and Jackson, Christopher and Yang, Isaac and Lim, Michael},
title = {Current Trends in Glioblastoma Multiforme Treatment: Radiation Therapy and Immune Checkpoint Inhibitors},
journal = {Brain Tumor Research and Treatment},
year = {2013},
doi = {10.14791/btrt.2013.1.1.2}
}
EUVIMED